Davorin Herceg

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries

Lidija Kandolf Sekulović, Jun Guo, Sanjiv S. Agarwala et al. · European Journal of Cancer · 2018 · 53 citations · Full text

Medicine, Dermatology, Oncology +15

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments

Lidija Kandolf Sekulović, Ketty Peris, Axel Hauschild et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Oncology, Metastasis +11

Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients

Ana Kulić, Maja Sirotković-Skerlev, Sanda Jelisavac-Čosić et al. · Medical Oncology · 2009 · 35 citations

Medicine, Cancer Biology, Oncology +14

Urokinase-type plasminogen activator and its inhibitor in thyroid neoplasms: a cytosol study

Gordana Horvatić Herceg, Davorin Herceg, Marko Kralik et al. · Wiener klinische Wochenschrift · 2006 · 24 citations

Medicine, Cancer Biology, Oncology +14

Urokinase Plasminogen Activator and Its Inhibitor Type‐1 as Prognostic Factors in Differentiated Thyroid Carcinoma Patients

Gordana Horvatić Herceg, Davorin Herceg, Marko Kralik et al. · Otolaryngology · 2013 · 19 citations

Medicine, Cancer Biology, Oncology +13